Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220007065 220002752 1.67 114 Curative (C) 2014-12-07 2014-12-06 Carboplatin + Paclitaxel (3 weekly) N N 220031596 CARBOPLATIN + PACLITAXEL
220007066 220002753 1.57 85.4 Curative (C) null 2014-01-10 AML 18 TRIAL 01 N 220031605 AML18 TRIAL
220007067 220002754 1.8 76.4 Curative (C) 2014-06-10 2014-07-17 AML16 DA 3+10 N null 220031606 AML16 TRIAL
220007068 220002755 1.68 81.3 Palliative (P) null 2013-02-28 Idarubicin+Tretinoin Spanish Crse1 02 N 220031607 IDARUBICIN + TRETINOIN
220007069 220002755 1.8 68 Palliative (P) 2018-08-31 2018-10-07 AML16 DA 3+10 N N 220031607 AML16 TRIAL
220007070 220002755 1.78 94 Palliative (P) 2013-09-18 2013-11-15 Cisplatin + Gemcitabine (D 1 & 8) N N 220031607 CISPLATIN + GEMCITABINE
220007071 220002756 null 73.2 Curative (C) 2018-06-04 2018-06-09 AML18 PILOT TRIAL 1 N 220031612 PILOT TRIAL
220007072 220002756 1.62 81.3 Curative (C) 2017-09-30 2017-09-30 Idarubicin+Tretinoin Spanish Crse1 99 N 220031612 IDARUBICIN + TRETINOIN
220007073 220002756 2.03 59.3 Curative (C) 2016-07-06 2016-07-12 AML18 PILOT TRIAL Y N 220031612 PILOT TRIAL
220007074 220002756 1.67 85.4 Curative (C) null 2014-02-09 AML 18 TRIAL Y N 220031612 AML18 TRIAL
220007075 220002756 null 85 Palliative (P) 2015-08-12 2015-08-17 GemCarbo Days 1+8 N N 220031612 GEMCARBO
220007076 220021270 1.16 83.7 Curative (C) null 2013-12-05 AML 18 TRIAL Y N 220031623 AML18 TRIAL
220007077 220021270 null 55 Palliative (P) 2017-09-09 2017-10-17 IDARUBICIN + TRETINOIN Y N 220031623 IDARUBICIN + TRETINOIN
220007078 220002757 1.69 65.6 Curative (C) 2016-06-05 2016-06-05 IDARUBICIN + TRETINOIN 2 N 220031628 IDARUBICIN + TRETINOIN
220007079 220011575 1.59 50 Curative (C) 2013-01-26 2013-02-01 AML18 PILOT TRIAL Y Y 220031631 PILOT TRIAL
220007081 220002759 1.65 63.2 Curative (C) 2017-03-21 2017-04-24 AML16 DA 3+10 N N 220031636 AML16 TRIAL
220007082 220002760 1.58 105 Curative (C) null 2014-10-14 AML 18 TRIAL Y N 220031639 AML18 TRIAL
220007083 220002761 null 79 Disease modification (D) 2017-06-29 2017-06-29 Dasatinib N N 220031644 DASATINIB
220007084 220002761 1.6 78 Curative (C) 2016-12-06 2017-01-08 AML16 DA 3+10 Y N 220031644 AML16 TRIAL
220007085 220002761 null null null 2017-10-22 2017-10-26 IDARUBICIN + TRETINOIN 2 N 220031644 IDARUBICIN + TRETINOIN
220007086 220002761 1.65 62.4 null 2015-06-05 2015-06-05 GEMCARBO N null 220031644 GEMCARBO
220007088 220002763 null 94.6 Palliative (P) 2016-05-29 2016-06-04 CARBOPLATIN + PACLITAXEL N null 220031653 CARBOPLATIN + PACLITAXEL
220007089 220002763 1.85 null Curative (C) 2014-11-06 2014-11-09 IDARUBICIN + TRETINOIN N N 220031653 IDARUBICIN + TRETINOIN
220007090 220002763 1.5 60.6 null 2013-11-06 2013-11-14 CARBOPLATIN + GEMCITABINE N N 220031653 GEMCARBO
220007091 220002763 1.68 72 Curative (C) 2013-12-26 2014-01-02 AML18 PILOT TRIAL Y N 220031653 PILOT TRIAL
220007092 220002764 1.73 54.1 null 2015-10-26 2015-10-26 Cisplatin + Gemcitabine (D 1 & 8) 2 N 220031672 CISPLATIN + GEMCITABINE
220007093 220002765 1.73 63 Palliative (P) 2013-11-15 2013-11-27 GemCarbo Days 1+8 2 N 220031678 GEMCARBO
220007094 220002765 1.69 53.3 Curative (C) 2013-11-26 2013-12-03 AML16 DA 3+10 N N 220031678 AML16 TRIAL
220007095 220002765 1.78 84.8 Palliative (P) 2016-08-04 2016-08-14 Carboplatin + Paclitaxel (3 weekly) 02 N 220031678 CARBOPLATIN + PACLITAXEL
220007096 220002765 1.79 60.3 Curative (C) null 2015-06-07 AML 18 TRIAL N N 220031678 AML18 TRIAL
220007097 220002765 1.69 72.2 Palliative (P) 2015-02-07 2015-02-12 Dasatinib 2 N 220031678 DASATINIB
220007098 220002765 null 89.6 Neo-adjuvant (N) null 2013-10-12 Carboplatin + Paclitaxel (3 weekly) 2 N 220031678 CARBOPLATIN + PACLITAXEL
220007099 220002765 1.74 69.3 Curative (C) null 2013-03-06 AML 18 TRIAL 1 N 220031678 AML18 TRIAL
220007100 220002766 1.61 71.45 Curative (C) 2014-04-26 2014-06-05 AML16 DA 3+10 null N 220031688 AML16 TRIAL
220007101 220002766 null 52 Curative (C) 2014-10-15 2014-10-15 Idarubicin+Tretinoin Spanish Crse1 02 N 220031688 IDARUBICIN + TRETINOIN
220007102 220002766 1.84 77.7 Palliative (P) 2015-01-27 2015-02-08 Idarubicin+Tretinoin Spanish Crse1 N N 220031688 IDARUBICIN + TRETINOIN
220007103 220002767 1.68 67 Palliative (P) 2015-09-18 2015-09-18 Carboplatin + Paclitaxel (3 weekly) 02 null 220031699 CARBOPLATIN + PACLITAXEL
220007104 220011580 1.58 66 Palliative (P) 2017-01-17 2017-01-22 Dasatinib N N 220031700 DASATINIB
220007105 220002768 1.5 66 Curative (C) 2014-04-05 2014-04-06 AML18 PILOT TRIAL 1 N 220031703 PILOT TRIAL
220007106 220002768 null 64.4 Palliative (P) 2016-09-02 2016-09-02 Carboplatin + Paclitaxel (weekly) 02 N 220031703 CARBOPLATIN + PACLITAXEL
220007109 220020403 1.8 null null 2015-05-16 2015-05-16 GemCarbo Days 1+8 02 N 220031713 GEMCARBO
220007110 220021272 1.86 84.9 Palliative (P) 2014-02-08 2014-02-18 Dasatinib 2 N 220031716 DASATINIB
220007111 220002769 1.6 0 Curative (C) 2017-12-05 2017-12-10 AML18 PILOT TRIAL Y N 220031718 PILOT TRIAL
220007112 220002770 1.85 82 Neo-adjuvant (N) 2017-08-03 2017-08-03 Carboplatin + Paclitaxel (3 weekly) N N 220031719 CARBOPLATIN + PACLITAXEL
220007113 220002770 1.84 0 Curative (C) 2016-09-08 2016-09-08 AML18 PILOT TRIAL 1 N 220031719 PILOT TRIAL
220007114 220002771 1.65 45 Palliative (P) 2016-03-07 2016-03-07 GemCarbo Days 1+8 N N 220031721 GEMCARBO
220007115 220002772 1.64 92.2 Palliative (P) 2013-05-13 2013-05-20 Cisplatin + Gemcitabine (D 1 & 8) 2 N 220031722 CISPLATIN + GEMCITABINE
220007116 220002772 1.54 82.6 Palliative (P) 2014-07-05 2014-07-13 AML16 Low Dose Cytarabine N N 220031722 AML16 TRIAL
220007117 220002773 1.59 46.5 Palliative (P) 2015-03-27 2015-03-27 Carboplatin + Paclitaxel (3 weekly) N N 220031728 CARBOPLATIN + PACLITAXEL
220007118 220002773 0 83 Palliative (P) 2014-12-11 2014-12-16 Dasatinib 02 N 220031728 DASATINIB